drugset / Trial / NCT02800590

Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy

NCT02800590 ↗

Phase 2 Completed 150 enrolled The Medicines Company
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a phase II, two-part, multiple-dose, dose-finding, single-blind study in adult participants undergoing elective colonoscopy for screening or diagnostic purposes. This study is designed to test various ABP-700 infusion regimens for rational selection of one or more dosage regimen(s) to be used for future clinical development of ABP-700 in procedural sedation.

Timeline

Start
2016-05
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ABP-700 Small molecule 30 ug/kg Intravenous
Subject ABP-700 Small molecule 40 ug/kg Intravenous
Subject ABP-700 Small molecule 45 ug/kg Intravenous

Indications

No indication recorded.